JANE STREET GROUP, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is and the CUSIP is 04280A900. A total of 4 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$392,449
-48.8%
15,100
-43.7%
0.00%
Q1 2024$766,480
-31.0%
26,800
-26.2%
0.00%
Q4 2023$1,110,780
+26.0%
36,300
+10.7%
0.00%
Q3 2023$881,336
-19.0%
32,800
+7.5%
0.00%
Q2 2023$1,087,630
+33.0%
30,500
-5.3%
0.00%
Q1 2023$817,880
-56.5%
32,200
-30.6%
0.00%
-100.0%
Q4 2022$1,881,984
-32.7%
46,400
-45.2%
0.00%0.0%
Q3 2022$2,796,000
+83.8%
84,600
+95.8%
0.00%0.0%
Q2 2022$1,521,00043,2000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 165$1,047,0000.09%
GROUP ONE TRADING, L.P. 119,900$7,605,0000.05%
SIMPLEX TRADING, LLC 745$4,725,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders